Periostin as a novel factor responsible for ventricular dilation

Circulation

Volumn 110, Issue 13, 2004, Pages 1806-1813

  Katsuragi, Naruto ^a   Morishita, Ryuichi ^b   Nakamura, Noriko ^a   Ochiai, Tayehito ^a   Taniyama, Yoshiaki ^b   Hasegawa, Yasuhiro ^a   Kawashima, Kayoko ^a   Kaneda, Yasufumi ^b   Ogihara, Toshio ^b   Sugimura, Keijiro ^a  

^a SUNTORY LTD   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adhesion; Gene therapy; Heart failure; Remodeling

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BRAIN NATRIURETIC PEPTIDE; CELL ADHESION MOLECULE; COLLAGEN; ENDOTHELIN 1; FIBRONECTIN; LACTATE DEHYDROGENASE; LIPOSOME; PERIOSTIN; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL SPREADING; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FIBROBLAST; GENE THERAPY; GENETIC TRANSFECTION; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; MALE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAINFLUENZA VIRUS 1; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL ADHESION MOLECULES; CELL LINE; CELL SIZE; CELLS, CULTURED; DNA, COMPLEMENTARY; FIBROBLASTS; FIBRONECTINS; GENE EXPRESSION REGULATION; HEMODYNAMIC PROCESSES; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCYTES, CARDIAC; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RATS; RATS, INBRED DAHL; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPODOPTERA; TRANSFECTION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 20844448896     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000142607.33398.54     Document Type: Article

References (32)

1. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691.
2. Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a β-cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999-1006.
3. Thierfelder L, Watkins H, MacRae C, et al. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994;77:701-712.
4. Watkins H, Conner D, Thierfelder L, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:434-437.
5. Bonne G, Carrier L, Bercovici J, et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:438-440.
6. Muntoni F, Cau M, Ganau A, et al. Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 1993;329:921-925.
7. Milasin J, Muntoni F, Severini GM, et al. A point mutation in the 5′ splice site of dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet. 1996;5:73-79.
8. Bione S, D'Adamo P, Maestrini E, et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet. 1996;12:385-389.
9. Megeney LA, Kablar B, Perry RL, et al. Severe cardiomyopathy in mice lacking dystrophin and MyoD. Proc Natl Acad Sci USA. 1999;96:220-225.
10. Jones WK, Grupp IL, Doetschman T, et al. Ablation of the murine α-myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest. 1996;98:1906-1917.
11. Arber S, Hunter JJ, Ross J Jr, et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell. 1997;88:393-403.
12. Sugaya T, Nishimatsu S, Tanimoto K, et al. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem. 1995;270:18719-18722.
13. Terasaki F. Overexpression of the human leukocyte tyrosine kinase in transgenic mice induces hypertrophic cardiomyopathy. Circulation. 1996;94(suppl I):I-187. Abstract.
14. Molkentin JD, Lu JR, Antos CL, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215-228.
15. Iwase M, Uechi M, Vatner, DE et al. Cardiomyopathy induced by cardiac Gsa overexpression. Am J Physiol. 1997;272:H585-H589.
16. Humphries DE, Sirokman G, Bing OH. Enhanced galactosyltransferase expression in the failing hearts of spontaneously hypertensive rats. Biochem Biophys Res Commun. 1996;218:320-324.
17. Zhu YZ, Zhu YC, Stoll M, et al. Identification of regulated genes in rat heart after myocardial infarction by means of differential mRNA display. Jpn Heart J. 2000;41:59-66.
18. Stanton LW, Garrard LJ, Damm D, et al. Altered patterns of gene expression in response to myocardial infarction. Circ Res. 2000;86:939-945.
19. Urasawa K, Yoshida I, Takagi C, et al. Enhanced expression of β-adrenergic receptor kinase 1 in the hearts of cardiomyopathic Syrian hamsters, BIO53.58. Biochem Biophys Res Commun. 1996;219:26-30.
20. Takeshita S, Kikuno R, Tezuka K, et al. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993;294:271-278.
21. Kaneda Y, Iwai K, Uchida T. Increased expression of DNA co-introduced with nuclear protein in adult rat liver. Science. 1989;243:375-378.
22. Itoh M, Tsukada S, Orita T, et al. Identification by differential display of eight known genes induced during in vivo intimal hyperplasia. J Hum Genet. 1998;43:9-13.
23. Peters DG, Kassam AB, Feingold E, et al. Molecular anatomy of an intracranial aneurysm: coordinated expression of genes involved in wound healing and tissue remodeling. Stroke. 2001;32:1036-1042.
24. Hystad ME, Klinge R, Spurkland A, et al. Contrasting cardiac regional responses of A-type and B-type natriuretic peptide to experimental chronic heart failure. Scand J Clin Lab Invest. 2000;60:299-309.
25. Goetsch SC, Hawke TJ, Gallardo TD, et al. Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol Genomics. 2003;14:261-271.
26. Sasaki H, Sato Y, Kondo S, et al. Expression of the periostin mRNA level in neuroblastoma. J Pediatr Surg. 2002;37:1293-1297.
27. Sasaki H, Yu CY, Dai M, et al. Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res Treat. 2003;77:245-252.
28. Horiuchi K, Amizuka N, Takeshita S, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor-β. J Bone Miner Res. 1999;14:1239-1249.
29. Elkins T, Hortsch M, Bieber AJ, et al. Drosophila fasciclin I is a novel homophilic adhesion molecule that along with fasciclin III can mediate cell sorting. J Cell Biol. 1990;110:1825-1832.
30. Kawamoto T, Noshiro M, Shen M, et al. Structural and phylogenetic analysis of RGD-CAP/βig-h3, a fasciclin-like adhesion protein expressed in chick chondrocytes. Biochim Biophys Acta. 1998;1395:288-292.
31. Hashimoto K, Noshiro M, Ohno S, et al. Characterization of a cartilage-derived 66kDa protein (RGD-CAP/βig-h3) that binds to collagen. Biochim Biophys Acta. 1997;1355:303-314.
32. Yoshioka N, Fuji S, Shimakage, M et al. Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 gene. Exp Cell Res. 2002;279:91-99.